Early extracorporeal life support experiences in 2 tertiary pediatric intensive care units in Turkey

Extracorporeal membrane oxygenation (ECMO) is a unique life-support modality offered to patients unresponsive to optimal medical therapy. The aim of this study was to evaluate early experiences with ECMO support in 2 tertiary Turkish pediatric intensive care units (PICUs). Materials and methods: We retrospectively evaluated a total of 10 ECMO-supported patients between March 2012 and March 2013 in Marmara and Ege University Hospital PICUs. We reported data regarding demographics, laboratory and diagnostic information, and the clinical course of the patients. Results: The study consisted of 6 males and 4 females from 5 months to 14 years of age (mean age: 0.5 ± 5.01 years) supported with ECMO. Out of the 10 patients, 8 were on venovenous ECMO for respiratory failure and 2 received venoarterial ECMO for cardiac failure. Mean ECMO and intensive care duration was 11.1 ±7.3 days and 23.5 ±17.8 days, respectively. Bleeding was the most common complication (60%). Forty percent of the patients were weaned from ECMO, among which 50% were discharged in good health without sequelae. Conclusion: Initial experiences build the learning curve of institutions, and our early results are encouraging. Giving time to heal to the right patient at the right time is the key to success.

Early extracorporeal life support experiences in 2 tertiary pediatric intensive care units in Turkey

Extracorporeal membrane oxygenation (ECMO) is a unique life-support modality offered to patients unresponsive to optimal medical therapy. The aim of this study was to evaluate early experiences with ECMO support in 2 tertiary Turkish pediatric intensive care units (PICUs). Materials and methods: We retrospectively evaluated a total of 10 ECMO-supported patients between March 2012 and March 2013 in Marmara and Ege University Hospital PICUs. We reported data regarding demographics, laboratory and diagnostic information, and the clinical course of the patients. Results: The study consisted of 6 males and 4 females from 5 months to 14 years of age (mean age: 0.5 ± 5.01 years) supported with ECMO. Out of the 10 patients, 8 were on venovenous ECMO for respiratory failure and 2 received venoarterial ECMO for cardiac failure. Mean ECMO and intensive care duration was 11.1 ±7.3 days and 23.5 ±17.8 days, respectively. Bleeding was the most common complication (60%). Forty percent of the patients were weaned from ECMO, among which 50% were discharged in good health without sequelae. Conclusion: Initial experiences build the learning curve of institutions, and our early results are encouraging. Giving time to heal to the right patient at the right time is the key to success.

___

  • Lequier L. Extracorporeal life support in pediatric and neonatal critical care: a review. J Intensive Care Med 2004; 19: 243–258.
  • Bartlett RH,  Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010; 76: 534–540.
  • Shelley CL, Rees NJ. Pediatric pulmonary physiology and pathophysiology. In: Short BL, Williams L, editors. ECMO Specialist Training Manual. 3rd ed. Ann Arbor, MI, USA: Extracorporeal Life Support Organization; 2010. pp. 29–36.
  • Hill JD, O’Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, Gerbode F. Prolonged extracorporeal oxygenation for acute posttraumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 1972; 286: 629–634.
  • Erek E, Haydin S, Onan B, Onan IS, Yazici P, Kocyigit O, Tanidir C, Yivli P, Odemis E, Yeniterzi M et al. Extracorporeal life support experiences of a new congenital heart center in Turkey. Artif Organs 2013; 37: E29–E34.
  • UK Collaborative ECMO Trial Group. UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75–82.
  • Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351–1363.
  • Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney AF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure: pediatric critical care study group. Crit Care Med 1996; 24: 323– 329.
  • Dalton H, Fortenberry JD, Frenckner B, Palmer P. ECMO for pediatric respiratory failure. In: Lynch WR, MacLaren G, Wilson JM, Bartlett RH, editors. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 4th ed. Ann Arbor, MI, USA: Extracorporeal Life Support Organization; 2012. pp. 265–291.
  • Trachsel D, McCridle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Resp Crit Care Med 2005; 172: 206–211.
  • The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301–1308.
  • Petrou S, Bischof M, Bennet C, Elbourne D, Field D, McNally H. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on the 7 year results from the United Kingdom Collaborative ECMO trial. Pediatrics 2006; 117: 1640–1649.
  • Karamlou T, Vafaeezadeh M, Parrish AM, Cohen GA, Welke KF, Permut L, McMullan DM. Increased extracorporeal membrane oxygenation center case volume is associated with improved extracorporeal membrane oxygenation survival among pediatric patients. J Thorac Cardiovasc Surg 2013; 145: 470–475.
  • Jen HC, Shew SB. Hospital readmissions and survival after nonneonatal pediatric ECMO. Pediatrics 2010; 125: 1217–1223.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Evaluation and comparison of alpha- and beta-amanitin toxicity on MCF-7 cell line

Ertuğrul KAYA, Recep BAYRAM, Kürşat Oğuz YAYKAŞLI, İsmail YILMAZ, Sait BAYRAM

Is the diagnosis and treatment of childhood acute bacterial meningitis in Turkey evidence-based?

Özden TÜREL, Mustafa BAKIR

Mei YONG, Ling YANG, Qimuge SUYILA, Wenyan HAN, Hongwei YUAN, Cheng ZHAO, Xiulan SU

Association between the apelin rs2235306 gene polymorphism and metabolic syndrome

Mohammad HASHEMI, Hamzeh REZAEI, Ebrahim ESKANDARI-NASAB

Investigating the effects of negative-calorie diet compared with low-calorie diet under exercise conditions on weight loss and lipid profile in overweight/obese middle-aged and older men

Mohammadreza REZAEIPOUR, Gennady Leonidovich APANASENKO, Vladimir Ivanovich NYCHYPORUK

Pittsburgh Sleep Quality Index scores and their relationship with body measurements in late menopause patients

Aylin AYRIM, Esra AKTEPE KESKİN, Duygu ÖZOL

Seroprevalences and associated risk factors of hepatitis B and C in adults

Mustafa YILDIRIM, Selma ÇAKIR, Mehmet Faruk GEYİK, Davut ÖZDEMİR, Ertuğrul GÜÇLÜ, Mehmet ÇAKIR

The effect of Malaysian honey and its major components on the proliferation of cultured fibroblasts

Al-mahdi AL-JADI, Francis Kanyan ENCHANG, Kamaruddin Mohd YUSOFF

Calcifying fibrous pseudotumor of lungs

Serdar Özkan Funda DEMİRAĞ, Erdal YEKELER, Nurettin KARAOĞLANOĞLU

The relation between Helicobacter pylori and ulcerative colitis

Sedat CANER, Akif ALTINBAŞ, Yusuf YEŞİL, Yavuz BEYAZIT, Barış YILMAZ, Osman YÜKSEL